...
机译:CHG灌注方案(低剂量红细胞,HOMOHARRINGOTONE和G-CSF)在较高风险MDS患者中复发或难以解决的疗效和毒性
Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Dept Hematol Shanghai 200233 Peoples R China;
Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Dept Hematol Shanghai 200233 Peoples R China;
Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Dept Hematol Shanghai 200233 Peoples R China;
Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Dept Hematol Shanghai 200233 Peoples R China;
Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Dept Hematol Shanghai 200233 Peoples R China;
Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Dept Hematol Shanghai 200233 Peoples R China;
Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Dept Hematol Shanghai 200233 Peoples R China;
Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Dept Hematol Shanghai 200233 Peoples R China;
Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Dept Hematol Shanghai 200233 Peoples R China;
Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Dept Hematol Shanghai 200233 Peoples R China;
Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Dept Hematol Shanghai 200233 Peoples R China;
Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Dept Hematol Shanghai 200233 Peoples R China;
Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Dept Hematol Shanghai 200233 Peoples R China;
Myelodysplastic syndromes; Decitabine; Cytarabine; Homoharringtonine; Granulocyte colony-stimulating factor (G-CSF);
机译:CHG灌注方案(低剂量红细胞,HOMOHARRINGOTONE和G-CSF)在较高风险MDS患者中复发或难以解决的疗效和毒性
机译:CHG方案(小剂量阿糖胞苷,高灵敏素联合G-CSF引发)作为高危MDS或由MDS转化为AML的老年患者的诱导化疗的疗效和安全性
机译:地西他滨与CHG方案(低剂量阿糖胞苷,高灵敏素和粒细胞集落刺激因子)在高危骨髓增生异常综合征患者中的疗效和毒性:一项回顾性研究
机译:Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物,最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
机译:低剂量次甲基化剂地西他滨联合阿克拉霉素和阿糖胞苷在难治性/复发性细胞遗传学和突变风险低的急性/复发性急性髓细胞白血病患者中取得比标准FLAG化疗更好的结果
机译:低剂量的低甲基化剂与海红霉素和红霉素组合的二亚滨达到了难治性/复发的急性髓性白血病患者的标准标志化疗的更好的结果,患有贫困的细胞遗传学和突变